Several states are probing pharmacy-benefit managers’ business practices in government-sponsored health programs, adding to the scrutiny the middlemen face in Washington for their role in the cost of drugs. At least three state attorneys general are investigating PBMs, in addition to other state probes looking into how the companies contract with Medicaid and other programs.… Continue reading PBMs Face State Probes Over Complex Pricing System
Tag: PBMs
Trump Targets Rebates to PBMs to Lower Drug Costs
The Trump administration proposed ending a complex system of drug rebates that influence tens of billions of dollars in U.S. pharmaceutical spending, a move that could upend the relationship between drugmakers and pharmacy benefits middlemen. The proposal, a long-awaited part of the administration’s plan to target high list prices of drugs, would ban rebates paid… Continue reading Trump Targets Rebates to PBMs to Lower Drug Costs